FDA Approves Esketamine Nasal Spray (Spravato™) for Treatment-Resistant Depression - WorkersCompensation.com

Submitted by Anonymous (not verified) on Thu, 03/14/2019 - 04:02

FDA Approves Esketamine Nasal Spray (Spravato™) for Treatment-Resistant Depression  WorkersCompensation.comEarlier this month, the Food and Drug Administration (FDA) approved esketamine nasal spray, which will be marketed by Johnson & Johnson (J&J) under the ...